A recent study conducted at the Southeast Louisiana Veterans Health Care System, New Orleans, LA, USA by the Section of Hematology and Medical Oncology, Tulane University School of Medicine, New Orleans, LA, evaluated the efficacy of the timely use of zoledronic acid (ZA) on clinical outcomes and health care utilization in men with bone-metastatic prostate [...]
Recently, I received two separate questions about both low dose ketoconazole (LDK) and high dose ketoconacole (HDK). For both of these men with castrate resistant advanced prostate cancer, their PSA scores continued to rise, despite their using keto. Even when taken properly, not all men experience a positive effect from the drug (a decline in [...]
Malecare is proud to announce that we are now partnering with the Clinical Trials Resource Center. This partnership allows us to offer you, through our web site (www.malecare.org), CenterWatch’s data base of clinical trials that are being conducted both in the United States and internationally. CenterWatch is the leading publisher of information on clinical research [...]
Of interest is a recent advanced prostate cancer survivor's post the cost of his treatments in 2010. His accompanying comments were: Often on these boards we discuss the cost of treating prostate cancer. Below you will find the summation of my 2010 medical costs. These are 100% prostate cancer related as I am otherwise healthy. [...]
Last Tuesday’s New York Times had a commentary, A Fighting Spirit Won’t Save Your Life caused me to pause and think. The author, Richard Sloan, who is a professor of behavioral medicine at the Columbia University Medical Center, is attempting to debunk the belief that getting sick is a punishment for being a bad person [...]